NR565 ADVANCED PHARMACOLOGY
FUNDAMENTALS COMPREHENSIVE
EXAM QUESTIONS AND VERIFIED
ANSWERS |GRADE A+|CHAMBERLAIN
COLLEGE
1. Which pharmacokinetic process is most significantly affected by a patient’s genetic
polymorphism of the CYP2D6 enzyme?
A. Absorption
B. Distribution
C. Excretion
D. Metabolism
Answer: D
Conceptual Explanation: CYP2D6 is a major enzyme in the cytochrome P450 system
responsible for the metabolism of many drugs; genetic polymorphisms can lead to poor,
intermediate, or ultra-rapid metabolism of substrates.
2. A patient with chronic kidney disease requires a medication that is primarily eliminated
renally. What adjustment is most likely necessary?
A. Decrease the dosing interval
,B. Increase the loading dose
C. Decrease the individual dose or increase the interval
D. Switch to an oral route to delay absorption
Answer: C
Conceptual Explanation: Renal impairment reduces the clearance of drugs, requiring a
reduction in dose or an increase in the dosing interval to prevent toxicity.
3. Which of the following describes the ‘first-pass effect’?
A. Rapid excretion of a drug by the kidneys upon first entry
B. The binding of a drug to plasma proteins during the first circuit
C. Metabolism of a drug in the liver before it reaches systemic circulation
D. The initial distribution of a drug to highly perfused organs
Answer: C
Conceptual Explanation: The first-pass effect occurs when an orally administered drug is
absorbed from the GI tract and carried via the portal vein to the liver, where it is
metabolized before reaching the rest of the body.
4. A drug has a half-life of 4 hours. How long will it take for the drug to reach approximately
94% steady state?
A. 8 hours
B. 12 hours
, C. 20 hours
D. 16 hours
Answer: D
Conceptual Explanation: Steady state is generally reached after 4 to 5 half-lives. 4 hours
multiplied by 4 half-lives equals 16 hours.
5. What is the clinical significance of a drug with a high volume of distribution (Vd)?
A. The drug remains primarily in the plasma
B. The drug is likely highly protein-bound
C. The drug is extensively distributed into tissues
D. The drug will have a very short half-life
Answer: C
Conceptual Explanation: A high Vd indicates that the drug is distributed widely
throughout the body tissues rather than being confined to the plasma.
6. Which medication is a potent inducer of the CYP450 system, potentially leading to reduced
efficacy of co-administered drugs?
A. Rifampin
B. Ketoconazole
C. Erythromycin
FUNDAMENTALS COMPREHENSIVE
EXAM QUESTIONS AND VERIFIED
ANSWERS |GRADE A+|CHAMBERLAIN
COLLEGE
1. Which pharmacokinetic process is most significantly affected by a patient’s genetic
polymorphism of the CYP2D6 enzyme?
A. Absorption
B. Distribution
C. Excretion
D. Metabolism
Answer: D
Conceptual Explanation: CYP2D6 is a major enzyme in the cytochrome P450 system
responsible for the metabolism of many drugs; genetic polymorphisms can lead to poor,
intermediate, or ultra-rapid metabolism of substrates.
2. A patient with chronic kidney disease requires a medication that is primarily eliminated
renally. What adjustment is most likely necessary?
A. Decrease the dosing interval
,B. Increase the loading dose
C. Decrease the individual dose or increase the interval
D. Switch to an oral route to delay absorption
Answer: C
Conceptual Explanation: Renal impairment reduces the clearance of drugs, requiring a
reduction in dose or an increase in the dosing interval to prevent toxicity.
3. Which of the following describes the ‘first-pass effect’?
A. Rapid excretion of a drug by the kidneys upon first entry
B. The binding of a drug to plasma proteins during the first circuit
C. Metabolism of a drug in the liver before it reaches systemic circulation
D. The initial distribution of a drug to highly perfused organs
Answer: C
Conceptual Explanation: The first-pass effect occurs when an orally administered drug is
absorbed from the GI tract and carried via the portal vein to the liver, where it is
metabolized before reaching the rest of the body.
4. A drug has a half-life of 4 hours. How long will it take for the drug to reach approximately
94% steady state?
A. 8 hours
B. 12 hours
, C. 20 hours
D. 16 hours
Answer: D
Conceptual Explanation: Steady state is generally reached after 4 to 5 half-lives. 4 hours
multiplied by 4 half-lives equals 16 hours.
5. What is the clinical significance of a drug with a high volume of distribution (Vd)?
A. The drug remains primarily in the plasma
B. The drug is likely highly protein-bound
C. The drug is extensively distributed into tissues
D. The drug will have a very short half-life
Answer: C
Conceptual Explanation: A high Vd indicates that the drug is distributed widely
throughout the body tissues rather than being confined to the plasma.
6. Which medication is a potent inducer of the CYP450 system, potentially leading to reduced
efficacy of co-administered drugs?
A. Rifampin
B. Ketoconazole
C. Erythromycin
